Essay On Essential Medicine

The pharmaceutical industry is one of the most powerful and greedy industries in our country, with a goal to make as large a profit as possible, at the expense of the sick.

"In the past two decades or so, health care has been commercialized as never before, and professionalism in medicine seems to be giving way to entrepreneurialism," commented Arnold S. Relman, professor of medicine and social medicine at Harvard Medical School (Wekesser 66). This statement may have a great deal of bearing on reality. The tangled knot of insurers, physicians, drug companies, and hospitals that we call our health system are not as unselfish and focused on the patients' needs as people would like to think. Pharmaceutical companies are particularly ruthless, many of them spending millions of dollars per year to convince doctors to prescribe their drugs and to convince consumers that their specific brand of drug is needed in

The current debate over the Mylan Company’s near monopoly of the epinephrine market through its EpiPen shows what can happen without monopoly regulation. While the cost to produce an Epipen is around $30, the price to the consumer is around $300 each. The economic implications for a family that needs to keep the device on hand to save a life can be excessively high, the emotional results of not having one when you need one are debilitating. This monopoly is further enhanced by state-enforced regulations requiring that schools keep EpiPens in stock and the, so-called, EpiPen law enacted in 2013, which leave little incentive for other pharmaceutical companies to develop their own technology for fast-acting emergency devices. (Bartolone, 2016) Breaking Mylan’s monopoly will not only lead to new product development but lower prices for consumers for a life-saving delivery

Even though this occurrence happened almost 70 years ago, the prevalent themes still exist today. The allure of pharmaceutical money and the use of drugs on patients, for instance, sway some doctors, even when they are unnecessary or, worse, harmful (Koch 1). Reading about Lacks, it is clearly recognizable how necessary it is to have a moral compass in a field that requires utter respect towards

The rise of medicalization has been affected by many social factors, and has caused a winning-and-losing situation for those caught in the middle. In Peter Conrad’s article The Shifting Engines of Medicalization, he explains how medicalization was constructed by three certain factors: first, the authority within the medical profession; second, the activities of social movements and interest groups; and third, the rise in behavioral pediatrics in terms of medical control of childhood diseases, and directed organizational professional activities (Conrad, 2005, p. 4). There have been debates that some things should no longer be treated as an illness in the medical sphere. Conrad explains how the pharmaceutical industries are more aggressive in promoting their products to physicians and to the public, which is empowered by the consumers becoming increasingly active in their demand for medical services and treatments (2005, p. 5, 9). Companies are marketing diseases (creating “epidemics” and drug scares within a society) and then selling the drugs to treat those diseases (Conrad, 2005, p. 6). Society and these companies make it seem as though these disorders and diseases can happen to anyone at any time.

Anyone who has purchased prescription medications has probably wondered why they cost so much, and rightfully so. Medication prices in the United States have been on a steady increase for decades, however, prices have been drastically increasing as of recent. Pharmaceutical companies have tried to justify these price increases due to the demand, the high cost of research, and the high costs of development and approval. Notwithstanding, the extent to which the prices have increased is not justifiable. Americans should be against these high medication prices and take action because pharmaceutical companies are taking advantage of our healthcare system in order to capitalize from the sick. In order shed some light on this issue, the magnitude, scope, and consequences of these prices must be examined.

Prescription drug prices are on the rise in the United States. Currently, the United States does not implement a price control on prescription drugs. Every day the supply and demand for prescription drugs fluctuates. Pharmaceutical companies produce drugs that are necessary for survival. Therefore, it is necessary for research and development to continue in the United States. Those suffering the effects of exorbitant prices must do so until a generic form of a prescription drug is produced. Once approved by the FDA, new drugs will make their appearance on the market and patients will no longer suffer financially. Until then, it is necessary for pharmaceutical companies to price their drugs based on the idea of supply and demand. This produces the profit used to fund research. Price controls discourage innovation. If a price control were set in place, of course the price of prescription drugs would decrease. However, the development of new drugs decreases with it. Today’s generation would benefit from lower prices, while future generations would suffer from the loss of drug innovation.

Anyone who has purchased prescription medications has probably wondered why they cost so much, and rightfully so. Medication prices in the United States have been on a steady increase for decades, however, prices have been drastically increasing as of recent. Pharmaceutical companies have tried to justify these price increases due to the demand, the high cost of research, and the high costs of development and approval. Notwithstanding, the extent to which the prices have increased is not justifiable. Americans should be against these high medication prices and take action because pharmaceutical companies are taking advantage of our health care system in order to capitalize from the sick. In order shed some light on this issue, we must examine the magnitude, scope, and consequences of these rises in price.

Even though the pharmaceutical industry had been highly profitable and contributed about 40% OF Ciba-Geigy’s revenues in profit, there were some trends, which were worrying. The government had attempted to reduce a cost of healthcare thus; pressure to lower costs was mounting on industrialized countries. There were restrictions to introduce new products, and price control became stricter while limiting the freedom of doctors to prescribe medications. Patent controls were becoming reduced, and the pharmaceutical industry was becoming increasingly criticized. These trends later made the industry to

The prices in which the medication are set are necessary for research and development. Roy P. Vagelos, discusses about the problems regarding restricting pharmaceutical companies in the written source Are Prescription Drug Prices High?. For instance, it can reduce the profits to support research investments, since it costs at least $231 millions dollars in order to bring one new prescription medicine to the market and in a pharmaceutical company like Merck, there are at least 4500 researchers who work to develop products (Vagelos 1). In other words, it costs millions for researches to develop at least one new drug to present to the market and it also costs to pay researchers to help develop these new drugs. In addition, the article The Real Cost of “High Priced” Drugs,

For Nelson, the rights of conscience to pharmacists to protect their refusal on all levels; to provide, to refer, and to education, is a necessity. This right is needed to prevent the extinction of ‘religious health care professionals. Nelson states, “If society is prepared to legalize controversial health care products and procedures, it must also work to protect those who do not agree with them”. This statement stands at the core of Nelson’s stance. If the patents have protective measures in choice on their end, then professionals should also.

Marketing and priorities of the pharmaceutical industry have been a dilemma for years. Scare- mongering has been increased on the importance of drugs (Shah, 2010). For example, executives at Mylan, a pharmaceutical company that owns Epipen, reportedly reaped in nearly three hundred million in compensation from 2011 to 2015 (Tuttle, 2016). Heather Bresch, the CEO of Mylan, was accused of jacking up the price by 600%; her response was to blame the “broken health system”, Obamacare, and the rise of high- deductible health insurance plan. But should this be the case to do these to millions of families who can barely afford something that take thirty dollars to make and jack the price up to seven hundred dollars? We live in a greedy nation that is only there to take from one another. When people see this you can only think of how the pharmaceuticals being an “industry” it basically prioritizes that revenue comes before the needs and cures to the human society.

-I agree that it is an appropriate change in policy. People tend to get greedy when large amounts of profit come flowing in blinding them of people’s real needs for help. The benefit of protecting the pharmaceutical patents is that it helps the poor get drugs at a lower cost actually giving them a chance, everyone deserves a chance. We are economically the most advanced compared to any other country we should want to help those who don’t have the means to help themselves. As many could potentially benefit from this policy it does have its problems. This policy would bring along some negative impact. For example, Pharmaceutical companies could face long term threats along with other risks.

Even though the pharmaceutical industry has made great improvements to human health and quality of life, like creating drugs for the treatment of AIDS, cancer, and other diseases, an increasing tension is growing between the public and the industry. These thoughts are fueled by issues such as drug pricing, affordable health care, and the battle against epidemic diseases in third world countries; social critics wonder whether this multi-billion dollar industry is giving enough back to the community and fulfilling its social responsibility.

Though it is common knowledge that pharmaceutical companies, insurance companies and biomedicine are all interconnected, Ordinary Medicine gives insight to the degree of power